{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Randomised clinical trials of off\u2010pump versus on\u2010pump CABG irrespective of language, publication status and blinding were selected for inclusion."
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "off\u2010pump versus on\u2010pump CABG"
      },
      "Objective": {
        "score": 1,
        "evidence": "Objectives: To assess the benefits and harms of off\u2010pump versus on\u2010pump CABG in patients with ischaemic heart disease."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Pooled analysis of all trials showed that off\u2010pump CABG increased all\u2010cause mortality compared with on\u2010pump CABG (189/5,180 (3.7%) versus 160/5144 (3.1%); RR 1.24, 95% CI 1.01 to 1.53; P =.04)."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Eighty\u2010six trials (10,716 participants) were included."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Pooled analysis of all trials showed that off\u2010pump CABG increased all\u2010cause mortality compared with on\u2010pump CABG (189/5,180 (3.7%) versus 160/5144 (3.1%); RR 1.24, 95% CI 1.01 to 1.53; P =.04)."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Pooled analysis of all trials showed that off\u2010pump CABG increased all\u2010cause mortality compared with on\u2010pump CABG (189/5,180 (3.7%) versus 160/5144 (3.1%); RR 1.24, 95% CI 1.01 to 1.53; P =.04)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant differences in myocardial infarction, stroke, renal insufficiency, or coronary re\u2010intervention were observed."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 12,
    "max_score": 25
  },
  "model": "gpt-4o"
}